Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: A validation study

2021

Additional Metadata
Keywords	anti-citrullinated protein antibodies, Autoantibodies, methotrexate, rheumatoid factor, tumor necrosis factor inhibitors
Persistent URL	doi.org/10.1136/annrheumdis-2020-219499, hdl.handle.net/1765/133758
Journal	Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Van Mulligen, E. (Elise), van der Helm-van Mil, A., & de Jong, P. (2021). Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: A validation study. Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases. doi:10.1136/annrheumdis-2020-219499

Publication